Epicriptine
From Infogalactic: the planetary knowledge core
(Redirected from Beta-Dihydroergocryptine)
<templatestyles src="Module:Hatnote/styles.css"></templatestyles>
Systematic (IUPAC) name | |
---|---|
(2R,4R,7R)-N- [(1S,2S,4R,7S)- 2-hydroxy- 7-(S)-(1-methylpropyl)- 5,8-dioxo- 4-(propan-2-yl)- 3-oxa- 6,9-diazatricyclo [7.3.0.02,6]dodecan-4-yl]- 6-methyl- 6,11-diazatetracyclo [7.6.1.02,7.012,16] hexadeca- 1(16),9,12,14-tetraene- 4-carboxamide
|
|
Clinical data | |
Pregnancy category |
|
Legal status |
|
Routes of administration |
Oral |
Identifiers | |
CAS Number | 19467-62-0 |
ATC code | N04BC03 (WHO) (alpha/beta) |
PubChem | CID: 3084313 |
ChemSpider | 2341400 |
UNII | 5M64643B5U |
ChEBI | CHEBI:59925 |
ChEMBL | CHEMBL1378681 |
Synonyms | beta-Dihydroergocryptine |
Chemical data | |
Formula | C32H43N5O5 |
Molecular mass | 577.715 g/mol |
|
|
|
Epicriptine or beta-dihydroergocryptine is a dopamine agonist of the ergoline class. It constitutes one third of the mixture known as dihydroergocryptine, the other two thirds consisting of alpha-dihydroergocryptine. The alpha differs from the beta form only in the position of a single methyl group, which is a consequence of the biosynthesis in which the proteinogenic amino acid isoleucine is replaced by leucine.[1]
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Drugs with non-standard legal status
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles containing unverified chemical infoboxes
- Dopamine agonists
- Oxazolopyrrolopyrazines
- Lactams
- Ergot alkaloids
- Lysergamides
- Nervous system drug stubs